In the Journals

Impaired spine mobility common after 10 years of ankylosing spondylitis

June 11, 2019
Patients with ankylosing spondylitis commonly demonstrate impaired spinal mobility after 10 years of disease duration, at which time a weakened…

Feature

Battle for Enbrel: Ruling on patent lawsuit could transform US biosimilar marketplace

June 10, 2019
Amgen is currently embroiled in two pivotal court cases surrounding patents for its bestselling etanercept product that could protect it from…

Feature

Imagine Dragons frontman raises awareness for ankylosing spondylitis with 'Monster Pain in the AS'

June 6, 2019
Dan Reynolds, lead singer for the Grammy Award-winning band Imagine Dragons, never wanted to talk about his diagnosis of ankylosing spondylitis. He…

In the JournalsPerspective

Rheumatologists vary on when to discontinue arthritis drugs during unplanned pregnancies

June 4, 2019
Although rheumatologists overwhelmingly agree on the use of conventional synthetic DMARDs and biologic drugs for inflammatory arthritis in patients…

In the JournalsPerspective

‘Substantial’ price increases continue for most popular brand-name drugs

May 31, 2019
Costs for the 49 top-selling brand-name prescription drugs in the United States increased by a median 76% between 2012 and 2017, with all but one…

In the Journals

Infertility, disease-related anxiety impact family size in women with RA

May 30, 2019
Fear and anxiety related to their disease, in addition to infertility, may impact family sizes of women with inflammatory arthritis, according to…

In the Journals

Golimumab efficacy maintained through 1 year in AS

May 28, 2019
Intravenous golimumab, administered in doses of 2 mg per kg, maintained its efficacy through 1 year in patients with ankylosing spondylitis, with no…

Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web…

Meeting News

Microbiome may contribute to all immune-related disease

May 13, 2019
DESTIN, Fla. — Multiple human and rodent studies suggest that the gut microbiome likely contributes to all diseases caused by a dysregulation…

Meeting News

Wearable tech can help assess disease flares

May 7, 2019
DESTIN, Fla. — Wearables are being used by patients with rheumatologic disease and research has indicated that clinicians can use activity…

Meeting News

Only 17% of patients with uveitis receive systemic disease evaluation, diagnoses

May 1, 2019
DESTIN, Fla. — Despite its common association with autoimmune diseases, just 17% of patients with uveitis are evaluated for, or diagnosed with…

Meeting News

Congress of Clinical Rheumatology to feature both well-known, 'off the circuit' speakers

April 30, 2019
More than 620 registered attendees from 45 states and 11 countries are traveling to Destin, Florida, this week for the 2019 Congress of Clinical…

In the JournalsPerspective

Sexual dysfunction common in patients with inflammatory arthritis

April 30, 2019
Sexual dysfunction is highly prevalent among men and women with inflammatory arthritis, with diseases-related factors impacting fluctuations in…

GuidelinesIn the Journals

ACR, Arthritis Foundation recommend against chronic glucocorticoids in JIA treatment

April 29, 2019
Health care providers should avoid prescribing chronic low-dose glucocorticoids — regardless of risk factors or disease activity — when…

FDA News

FDA approves Eticovo, second Enbrel biosimilar

April 26, 2019
The FDA has approved the second biosimilar to etanercept, etanercept-ykro, for all eligible indications of the biologic product, according to an FDA…

In the Journals

More than half of patients in AS remission relapse after ceasing infliximab

April 26, 2019
Approximately 58% of patients in clinical remission after taking infliximab for ankylosing spondylitis relapse within 12 months after discontinuing…

Meeting News

Collaboration between ophthalmologists, rheumatologists needed for immunosuppression

April 8, 2019
CHICAGO — Rheumatologists should make greater efforts to collaborate with ophthalmologists to better care for patients with inflammatory and…

FDA News

FDA approves Cimzia for nonradiographic axial SpA

March 28, 2019
The FDA has approved Cimzia for the treatment of adults with nonradiographic axial spondyloarthritis with objective signs of inflammation, making it…

In the Journals

Inflammatory disease linked to higher depression, anxiety rates

March 28, 2019
Primary care patients with inflammatory disease, particularly those with early-onset disease, demonstrate elevated rates of depression and anxiety…

In the Journals

Certolizumab pegol superior to placebo in non-radiographic axial SpA

March 19, 2019
The addition of certolizumab pegol to background medication for nonradiographic axial spondyloarthritis is superior to adding placebo, according to…